September 2010

A Coherent, Dependable Scheme Is Needed to Protect All Participants. Part One of a Two-Part Article

By Blaine Templeman

While the current clinical trial scheme in the United States requires sponsors of trials to provide potential participants disclosure as to known possible risks of participating, there is no coherent and dependable scheme in this country for the protection of patients, hospitals and sponsors against the costs posed by clinical trial injury.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

Pay per view ($20.00)